We report a case of a 41 year old patient with a first seizure after using a synthetic cannabinoid.

Magnetic resonance imaging showed extensive bilateral, mainly frontal, white matter lesions.

Genetic testing proved the diagnosis of adrenoleukodystrophy.

We hypothesize that cannabinoids might contribute to metabolic decompensation of adrenoleukodystrophy.